Orphan Drug Designation Granted to Gene Therapy Program for Infantile Batten – Rare Disease Report
Rare Disease ReportOrphan Drug Designation Granted to Gene Therapy Program for Infantile BattenRare Disease ReportThis morning, Abeona Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to … Continue reading
